Exciting immunotherapies for lymphoma presented at ASH 2019

ORLANDO — Joshua Brody, MD, director of the lymphoma immunotherapy program, Icahn School of Medicine at Mount Sinai, spoke about exciting data on novel immunotherapies for different types of lymphoma presented at ASH Annual Meeting & Exposition. Along with promising results from a large CAR-T cell trial for mantle cell lymphoma, Brody discussed the effectiveness of bispecific

Read the full article here

Related Articles